Pancreatitis in a child after rectal administration of 5-aminosalicylic Acid.

Inflamm Bowel Dis

Department of Pediatrics, Hvidovre Hospital, Hvidovre, Denmark.

Published: January 2013

: A case of 5-aminosalicylic acid (5-ASA)-induced pancreatitis in a 7-year-old girl with ulcerative colitis is described. Pancreatitis was first diagnosed after 7 months of treatment with 5-ASA by mouth. When she later received 5-ASA rectally, pancreatitis recurred after 2 weeks of treatment. She rapidly recovered after withdrawal of 5-ASA.

Download full-text PDF

Source

Publication Analysis

Top Keywords

5-aminosalicylic acid
8
pancreatitis
4
pancreatitis child
4
child rectal
4
rectal administration
4
administration 5-aminosalicylic
4
acid case
4
case 5-aminosalicylic
4
acid 5-asa-induced
4
5-asa-induced pancreatitis
4

Similar Publications

Anaemia is a frequent consequence of many gastrointestinal (GI) diseases in children and it can even be the initial presenting symptom of underlying chronic GI disease. The definition of anaemia is age and gender-dependent and it can be classified based on pathophysiology, red cell morphology, and clinical presentation. Although nutritional deficiencies, including GI malabsorption of nutrients and GI bleeding, play a major role, other pathophysiologic mechanisms seen in chronic GI diseases, whether inflammatory (e.

View Article and Find Full Text PDF

Acute liver failure (ALF) is characterized by rapid hepatic dysfunction, primarily caused by drug-induced hepatotoxicity. Due to the lack of satisfactory treatment options, ALF remains a fatal clinical disease, representing a grand challenge in global health. For the drug repositioning to ALF of mesalamine, which is clinically approved for the treatment of inflammatory bowel disease (IBD), we propose a supramolecular prodrug nanoassembly (SPNs).

View Article and Find Full Text PDF

The 5-aminosalicylic acid (5-ASA) agents are first-line drugs for ulcerative colitis (UC). However, intolerance as well as other issues have been reported for these drugs, making it difficult to sustain this treatment; accordingly, the persistence of 5-ASA is an important indicator of UC treatment strategy. We aimed to analyze the persistence of 5-ASA in patients with UC in Japan.

View Article and Find Full Text PDF

Background: Inflammatory bowel disease (IBD) is a persistent inflammation of the digestive system, and Mesenchymal Stem Cells (MSCs) and their exosomes have demonstrated potential as treatments for this condition. The objective of this research was to examine the possible effectiveness of intraperitoneal injection of umbilical cord-MSCs (UC-MSCs) and their exosomes through a two-time injection regimen in a mouse model.

Method: In this study, an animal model of a specific type of IBD in C57BL/6 mice, induced by dextran sulfate sodium (DSS), was utilized.

View Article and Find Full Text PDF

Background: 5-Aminosalicylic acid (5-ASA), the first-line therapy for ulcerative colitis, is a poorly soluble zwitterionic drug. Unformulated 5-ASA is thought to be extensively absorbed in the small intestine.

Methods: The pH-dependent solubility of 5-ASA in vitro and the intestinal membrane distribution of 5-ASA and its N-acetyl metabolite (AC-5-ASA) after the oral administration of 5-ASA were examined in fed rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!